The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

por Koleva-Kolarova, R G, Greuter, M J W, van Kruchten, M, Vermeulen, K M, Feenstra, T, Buskens, E, Glaudemans, A W J M, de Vries, E F J, de Vries, E G E, Hospers, G A P, de Bock, G H
Publicado 2015